Pharmafile Logo
Pharmafocus logo
Advanced Search

EFPIA

Showing 15 posts of 51 posts found.

uk_location_in_the_eu_2016

Pharma industry calls for EMA relocation by June in open EFPIA letter

April 25, 2017
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA

Heads of research from 19 of the biggest players in the industry have called for a decision to be made …

News
nathalie_moll

EFPIA names first female Director General

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA

Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …

Appointment
nathalie_moll

EFPIA names new first female Director General Nathalie Moll

February 24, 2017
Business Services, Medical Communications, Sales and Marketing EFPIA, appointment

Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …

News
pillsphotos1

The Pharmafocus debate: Is the price of new hepatitis C treatments fair?

April 27, 2015
Research and Development, Sales and Marketing Doctors of the World, Drug pricing, EFPIA, Gilead, MSF, drug cost, hepatitis C, patents, sofosbuvir, sovaldi

YES – says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that …

Feature
EMA image

EMA launches consultation on clinical trials

January 22, 2015
Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency

The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …

News
EMA image

Adaptive licensing could ‘transform industry’

December 17, 2014
Research and Development, Sales and Marketing Clinical Pharmacology & Therapeutics, EFPIA, EMA, MHRA, adaptive licesning

Drug regulators should switch to adaptive pathways as the preferred approach to bringing future new medicines to patients, according to …

News
Sanofi image

Sanofi looking to diversify, may buy into animal health

December 11, 2014
Manufacturing and Production, Research and Development, Sales and Marketing EFPIA, Jimenez, Sanofi, Serge Weinberg, Viehbacher, animal health

Sanofi is looking to diversify and is even considering buying into the consumer and animal health markets according to its …

News
Joe Jimenez image

EFPIA gives president role to Novartis chief executive

December 10, 2014
Medical Communications, Sales and Marketing EFPIA, Novartis, Sanofi, Witty, garidel, joe jimenez, oschmann

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has named Novartis chief executive Joe Jimenez as its new president. …

News
andy-powrie-smith

ABPI director jumps ship to EFPIA

December 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, Whitehead, andrew powrie-smith, andrew-powrie-smith

ABPI director Andrew Powrie-Smith is leaving the body to join The European Federation of Pharmaceutical Industries and Associations (EFPIA) as …

Appointment

Microsoft unveils new operating system

October 1, 2014
Medical Communications, Sales and Marketing EFPIA, Microsoft, Operating Systems, Solidsoft, start, windows 10

Microsoft has announced its next operating system is now due for release next year and is to host a variety …

News

MHRA leads social media drug safety initiative

September 8, 2014
Medical Communications, Sales and Marketing EFPIA, EU, MHRA, social media, web-radr

The MHRA has announced that it is to lead European medicines regulators, academics and pharma in a three-year project to …

News
Jane Griffiths, company group chairman for Janssen EMEA and chairwoman of the EF

Janssen: why transparency is essential to the health of our industry

August 29, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency

The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …

News
ema_building_face_web

EMA transparency agenda sees more delay

April 9, 2014
Medical Communications, Sales and Marketing AbbVie, EFPIA, EMA, Europe, InterMune, alltrials, parliament, transparency

The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …

News
Glenis Willmott

EU votes for trial transparency

April 3, 2014
Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott

Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …

News
elizabeth_kuiper_efpia

EFPIA hires director of European affairs

March 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, kuiper

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Elizabeth Kuiper to be the director of its European …

Appointment

Latest content

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023

EC approves Pfizer’s Litfulo for adolescents and adults with alopecia

September 19, 2023